Atropine is often considered a first-line intervention for unstable bradycardia. Unfortunately, atropine often fails when the bradycardia is not vagally-induced and is not indicated for high-level ...
Medtronic announced today that it received FDA approval for an expanded indication for its OmniaSecure defibrillation lead.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results